Breaking News, Collaborations & Alliances

AGC Biologics, ATUM Partner to Shorten Timelines for Cell Line Development

AGC to integrate ATUM’s Leap-In Transposase expression platform within its offerings.

Author Image

By: Charlie Sternberg

Associate Editor

Global biopharmaceutical contract development and manufacturing organization (CDMO) AGC Biologics is expanding its Cell Line Development Center of Excellence by partnering with ATUM to integrate the Leap-In Transposase expression platform within its offerings. This partnership provides drug developers with technology designed to increase yields and significantly shorten the path to clinical trials, directly addressing the market’s need for speed and efficiency. With ATUM’s modern transposa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters